Gut Microbiota, Inflammation, and Colorectal Cancer
- PMID: 27607555
- PMCID: PMC5541233
- DOI: 10.1146/annurev-micro-102215-095513
Gut Microbiota, Inflammation, and Colorectal Cancer
Abstract
Colorectal cancer is the second-leading cause of cancer-related deaths in the United States and fourth-leading cause of cancer-related deaths worldwide. While cancer is largely considered to be a disease of genetic and environmental factors, increasing evidence has demonstrated a role for the microbiota (the microorganisms associated with the human body) in shaping inflammatory environments and promoting tumor growth and spread. Herein, we discuss both human data from meta'omics analyses and data from mechanistic studies in cell culture and animal models that support specific bacterial agents as potentiators of tumorigenesis-including Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, and colibactin-producing Escherichia coli. Further, we consider how microbes can be used in diagnosing colorectal cancer and manipulating the tumor environment to encourage better patient outcomes in response to immunotherapy treatments.
Keywords: Fusobacterium; colitis; colorectal cancer; inflammation; microbiota/microbiome; mucosal immunology.
Figures




Similar articles
-
Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.Anaerobe. 2018 Feb;49:63-70. doi: 10.1016/j.anaerobe.2017.12.008. Epub 2017 Dec 19. Anaerobe. 2018. PMID: 29277623 Review.
-
Microbes and inflammation in colorectal cancer.Cancer Immunol Res. 2013 Sep;1(3):150-7. doi: 10.1158/2326-6066.CIR-13-0101. Cancer Immunol Res. 2013. PMID: 24777677 Review.
-
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review.
-
The Role of the Microbiome in Gastrointestinal Cancer.Gastroenterol Clin North Am. 2016 Sep;45(3):543-56. doi: 10.1016/j.gtc.2016.04.010. Gastroenterol Clin North Am. 2016. PMID: 27546848 Free PMC article. Review.
-
[Gut microbiota: What impact on colorectal carcinogenesis and treatment?].Bull Cancer. 2018 Jan;105(1):70-80. doi: 10.1016/j.bulcan.2017.10.025. Epub 2017 Dec 6. Bull Cancer. 2018. PMID: 29217301 Review. French.
Cited by
-
Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections.World J Gastroenterol. 2021 Apr 14;27(14):1465-1482. doi: 10.3748/wjg.v27.i14.1465. World J Gastroenterol. 2021. PMID: 33911468 Free PMC article.
-
Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.Sci Signal. 2020 Jul 21;13(641):eaba9157. doi: 10.1126/scisignal.aba9157. Sci Signal. 2020. PMID: 32694172 Free PMC article.
-
Intestinal Microbiota Influences DNA Methylome and Susceptibility to Colorectal Cancer.Genes (Basel). 2020 Jul 16;11(7):808. doi: 10.3390/genes11070808. Genes (Basel). 2020. PMID: 32708659 Free PMC article.
-
Fucoxanthin and Colorectal Cancer Prevention.Cancers (Basel). 2021 May 14;13(10):2379. doi: 10.3390/cancers13102379. Cancers (Basel). 2021. PMID: 34069132 Free PMC article. Review.
-
Age-related changes in intestinal immunity and the microbiome.J Leukoc Biol. 2021 Jun;109(6):1045-1061. doi: 10.1002/JLB.3RI0620-405RR. Epub 2020 Oct 5. J Leukoc Biol. 2021. PMID: 33020981 Free PMC article. Review.
References
-
- Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–23. Distinguished the roles of colibactin-producing E. coli in inflammation and tumorigenesis using animal models. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical